Health CanadaGeneral Alert
Association of Microangiopathic anemia with the combined use of AVASTIN (bevacizumab) and sunitinib malate in metastatic renal cell carcinoma - Notice to Hospitals
Published: July 11, 2008Recall ID: 24374Category: generalCountry: Canada
Safety AlertHealth Canada
Canada
Association of Microangiopathic anemia with the combined use of AVASTIN (bevacizumab) and sunitinib malate in metastatic renal cell carcinoma - Notice to Hospitals
Recalling Firm: Marketed health products
Product Description & Identification
Association of Microangiopathic anemia with the combined use of AVASTIN (bevacizumab) and sunitinib malate in metastatic renal cell carcinoma - Notice to Hospitals
Additional Source Details
| Field | Value |
|---|---|
| N I D | 24374 |
| U R L | https://recalls-rappels.canada.ca/en/alert-recall/association-microangiopathic-anemia-combined-use-avastin-bevacizumab-and-sunitinib |
| Title | Association of Microangiopathic anemia with the combined use of AVASTIN (bevacizumab) and sunitinib malate in metastatic renal cell carcinoma - Notice to Hospitals |
| Archived | 1 |
| Category | Drugs - Biologic or vaccine |
| Last updated | 2008-07-11 |
| Organization | Marketed health products |
Check Other Products In Your Household
Free Safety ToolsSafety recalls are issued daily across foods, medications, vehicles, and electronics. Use our instant tools to check your home for active safety warnings:
Overview
- Recalling FirmMarketed health products
Recall Hazard Severity
Official Agency AlertCaution (Class III)
📢 Share Warning
Alert family and friends to keep them safe. Copy this quick alert message:
🚨 SAFETY ALERT: Marketed health products - Association of Microangiopathic anemia with the combined use of AVASTIN (bevacizumab) and sunitinib malate in metastatic renal cell carcinoma - Notice to Hospitals Check if your household is affected: https://therecallfile.com/recalls/association-of-microangiopathic-anemia-with-the-combined-use-of-avasti/CANADA-24374
Join Alertlist
Get instant email updates whenever critical safety recalls like this are published.
Support The Recall File
Help keep official recall alerts free, accessible, and fast for everyone.
Spread the WordAssociation of Microangiopathic anemia with the combined use of AVASTIN (bevacizumab) and sunitinib malate in metastatic renal cell carcinoma - Notice to Hospitals